Login
$CVRX
$1.45 +$0.03 (2.11%) Close

$CVRX 4 SEC Filings

Filed On Filing
13 Aug 2026 Form 4: Binkowski Brent, CHIEF OPERATING OFFICER

Bought 26,223 shares ($76.4K)

13 Aug 2026 Form 4: Binkowski Brent, CHIEF OPERATING OFFICER

Sold 1,309 shares ($3.34K)

03 Jun 2026 Form 4: Nielsen Kirk G., Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Jain Mudit K., Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Slattery Joseph P, Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Hill, Mitch C., Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Ballinger Kevin J., Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Shadan Martha, Director

Received 8,720 shares as a grant or award · Granted 11,182 Stock Option (right to buy)

03 Jun 2026 Form 4: Dale Michael D, Director

Received 29,005 shares as a grant or award · Granted 36,252 Stock Option (right to buy)

16 Mar 2026 Form 4: Adamson Philip B., Chief Medical Officer

Received 41,000 shares as a grant or award · Granted 62,000 Stock Option (right to buy) · Sold 1,262 shares ($9.97K)

04 Mar 2026 Form 4: Morrison Gregory, CHIEF HUMAN RESOURCES OFFICER

Received 34,000 shares as a grant or award · Granted 154,500 Stock Option (right to buy)

03 Mar 2026 Form 4: Verrastro Paul, CHIEF MKTG & STRAT OFFICER

Received 45,000 shares as a grant or award · Granted 67,000 Stock Option (right to buy) · Sold 1,284 shares ($10.1K)

03 Mar 2026 Form 4: Hykes Kevin, Director

Received 159,000 shares as a grant or award · Granted 238,000 Stock Option (right to buy) · Sold 7,763 shares ($61.3K)

03 Mar 2026 Form 4: John Robert Allen, Chief Revenue Officer

Received 35,000 shares as a grant or award · Granted 52,000 Stock Option (right to buy) · Sold 3,964 shares ($31.3K)

03 Mar 2026 Form 4: Oasheim Jared, CHIEF FINANCIAL OFFICER

Received 61,000 shares as a grant or award · Granted 91,000 Stock Option (right to buy) · Sold 1,744 shares ($13.8K)

03 Mar 2026 Form 4: Binkowski Brent, CHIEF OPERATING OFFICER

Received 15,000 shares as a grant or award · Granted 23,000 Stock Option (right to buy)

23 Feb 2026 Form 4: Jain Mudit K., Director

Bought 46,800 shares ($298K)

18 Feb 2026 Form 4: Jain Mudit K., Director

Bought 600 shares ($2.79K)

01 Dec 2025 Form 4: Johnson & Johnson, 10% owner and 1 other

Sold 6,337 shares ($63.6K)

25 Nov 2025 Form 4: Johnson & Johnson, 10% owner and 1 other

Sold 500 shares ($5K) · Sold 2,200 shares ($22.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support